Description
BLOOD REAGENTS
First action · last action
2021-10-01 · 2021-10-01
Transactions
1
First transaction's obligation
$26,843
Base + all options value (sum of deltas)
$26,843
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))
Set-aside
—
Offers received
—
SDVOSB flag on record
Yes (self-representation)
Parent IDV
36C24221D0120
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-10-01+$26,843= $26,843
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-10-01 | +$26,843 | $26,843 | BLOOD REAGENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GHZKSZNTA2N5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0029 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $29,126 | FY2026 |
| 36C24225N0084 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $29,126 | FY2025 |
| 36F79724D0103 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $0 | FY2024 |
| 36C24224N0134 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $38,028 | FY2024 |
| 36C24222N0609 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $49,214 | FY2022 |
| 36C24221N0628 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $6,309 | FY2021 |
Other recipients under 6550 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24226N0602 | ORTHO-CLINICAL DIAGNOSTICS, INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $326,624 | FY2026 |
| 36C24226N0475 | BIOMERIEUX INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $251,376 | FY2026 |
| 36C24226N0479 | BIOMERIEUX INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $299,794 | FY2026 |
| 36C24226N0476 | BIOMERIEUX INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $277,267 | FY2026 |
| 36C24226N0477 | BIOMERIEUX INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $65,679 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24222N0126_3600_36C24221D0120_3600 · retrieved 2026-09-26.